Coronavirus Global Updates 28 July ::: Global cases of COVID-19 top 194, 7 million and U.S. to retain travel restrictions
Bulls n Bears
bulls at bullszimbabwe.com
Wed Jul 28 08:59:27 CAT 2021
<https://bullszimbabwe.com/>
<http://www.bullszimbabwe.com> Bullszimbabwe.com <mailto:info at bulls.co.zw?subject=View%20and%20Comments> Views & Comments <https://bullszimbabwe.com/category/blogs/bullish-thoughts/> Bullish Thoughts <http://www.twitter.com/BullsBears2010> Twitter <https://www.facebook.com/BullsBearsZimbabwe> Facebook <http://www.linkedin.com/pub/bulls-n-bears-zimbabwe/57/577/72> LinkedIn <https://chat.whatsapp.com/CF6wllAfScU9Wr6dXxoQnO> WhatsApp <mailto:info at bulls.co.zw?subject=Unsubscribe> Unsubscribe
Coronavirus Global Updates 28 July ::: Global cases of COVID-19 top 194,7 million and U.S. to retain travel restrictions
Zimbabwe COVID19 Update
COVID-19 update: As at 27 July 2021, Zimbabwe had 101 711 confirmed cases, including 70 496 recoveries and 3 280 deaths. To date, a total of 1 522 150 people have been vaccinated against COVID-19.
Global cases of COVID-19 top 194,7 million and U.S. to retain travel restrictions
The global tally for the coronavirus-borne illness climbed above 194.7 million on Tuesday, while the death toll climbed above 4.16 million, according to data aggregated by Johns Hopkins University.
The U.S. leads the world with a total of 34.5 million cases and in deaths with 611,007 as the highly infectious delta variant continues to spread fast, especially in states with low vaccination rates.
The federal government will keep existing COVID-19 travel restrictions on international travel in place for now due to concerns about the surging infection rate because of the delta variant, the Associated Press reported. It was the latest sign that the White House is having to recalibrate its thinking around the coronavirus pandemic as the more infectious variant surges across the U.S. and a substantial chunk of the population resists vaccination.
India is second by cases at 31.4 million and third by deaths at 421,382, according to its official numbers, which are expected to be undercounted. Brazil is second in deaths at 550,502, but is third in cases at 19.7 million.
Mexico has fourth-highest death toll at 238,595 but has recorded just 2.7 million cases, according to its official numbers. In Europe, Russia continues to pull ahead of the U.K. by deaths at 152,836, while the U.K. has 129,460, making Russia the country with the fifth-highest death toll in the world and highest in Europe.
COVID-19: What you need to know about the coronavirus pandemic on 27 July
1. How COVID-19 is affecting the globe
Confirmed cases of COVID-19 have passed 194.7 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.16 million. More than 3.89 billion vaccination doses have been administered globally, according to Our World in Data.
New daily COVID-19 cases in the Australian state of New South Wales have hit a 2021 high, with 172 new confirmed cases reported, the most since March 2020. The neighbouring state of Victoria has announced, however, that it will lift a strict lockdown.
Bhutan has given most of its population a second COVID-19 vaccine dose just one week after appealing for global donations.
Authorities in New York City and California have ordered government workers to get a COVID-19 vaccine or face regular tests.
South Korea has begun a COVID-19 vaccination drive for workers at vital computer chip and electronic businesses to maintain global supply chains.
Moderna is in discussion with US regulators to expand its ongoing trial of its COVID-19 vaccine in children between ages 5 and 11.
The US Centers for Disease Control and Prevention (CDC) and the State Department have warned against travel to Spain, Portugal, Cyprus and Kyrgyzstan because of rising COVID-19 cases in those countries.
Russia has approved a clinical trial combining doses of the AstraZeneca/Oxford COVID-19 vaccine with the Russian Sputnik V vaccine.
The UK government has expanded a programme of daily COVID-19 tests to reduce staff shortages caused by a high number of cases and strict isolation rules for those who come into contact with a positive case.
2. Biden pushes for long COVID patients to be protected by law
US President Joe Biden said yesterday that the White House is pushing for those with symptoms of so-called long COVID to be protected against discrimination.
"Many Americans who seemingly recovered from the virus still face lingering challenges like breathing problems, brain fog, chronic pain or fatigue," Biden said. "These conditions can sometimes rise to the level of a disability."
Around one in10 COVID-19 patients are still unwell 12 weeks after their acute infection - and many suffer symptoms much longer, according to a World Health Organization (WHO)-led investigation.
The new push will aim to see that long COVID patients "have access to the rights and resources that are due under the disability law".
3. Mixed AstraZeneca-Pfizer shots boost antibody level
A mixed vaccination programme of AstraZeneca and Pfizer/BioNTech shots boosted neutralizing antibody levels by six-time, compared with two AstraZeneca doses, a South Korean study has shown.
The study involved 499 medical workers - 100 receiving mixed doses, 200 taking two doses of the Pfizer/BioNTech shot and the remainder getting two AstraZeneca shots.
All showed neutralizing antibodies, which prevent the virus from entering cells and replicating, and the result of the mixed schedule of vaccines showed similar amounts of neutralizing antibodies found from the group that received two Pfizer shots.
A study in the UK has also shown similar results.
Global Covid-19 caseload tops 195 mn, deaths surge past 4.18 mn
global Covid-19 caseload has topped 195 million, while the deaths have surged to more than 4.18 million and vaccinations soared to over 3.84 billion, according to the Johns Hopkins University.
In its latest update on Tuesday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload, death toll and the total number of vaccine doses administered stood at 195,346,146, and 4,182,831, respectively.
The US continues to be the worst-hit country with the world's highest number of cases and deaths at 35,287,269 and 627,039, respectively, according to the CSSE.
In terms of infections, India follows in the second place with 31,439,764 cases.
The other worst countries with over 3 million cases are Brazil (19,707,662), Russia (6,149,780), France (5,999,244), the UK (5,722,298), Turkey (5,618,417), Argentina (4,859,170), Colombia (4,736,349), Spain (4,342,054), Italy (4,320,530), Germany (3,764,419), Iran (3,723,246) and Indonesia (3,194,733), the CSSE figures showed.
In terms of deaths, Brazil comes second with 550,586 fatalities.
Nations with a death toll of over 100,000 are India (421,411), Mexico (238,424), Peru (195,973), Russia (154,601), the UK (129,172), Italy (127,971), Colombia (119,182), France (111,667) and Argentina (104,105).
--IANS
Indonesia's COVID-19 deaths reach new heights
COVID-19 deaths in Indonesia, the hardest-hit country in Southeast Asia's latest surge, passed 2,000 for the first time today, with the country signaling that it may add a booster dose of Sinovac vaccine, due to concerns about protection gaps.
Elsewhere, cases are climbing steeply in Tokyo in the midst of the Summer Olympic Games, and in Australia, a lockdown expired in Victoria state, as another was extended in New South Wales as the Sydney area continues to grapple with ongoing COVID-19 activity.
Indonesia weighs Sinovac booster dose
Indonesia's daily record of 2,069 deaths today reflects 600 more fatalities than the nation reported yesterday, according to Agence France-Presse (AFP), which cited health ministry figures. New infections have declined some but are still at very high levels, with about 45,000 new cases reported today.
Though offices are still under shutdown orders, the government has allowed small shops and some restaurants and malls to reopen. So far, only 7% of the country is vaccinated, and officials are falling behind on their plans to give 1 million shots a day this month.
The country's health ministry said it is considering a booster dose of the Chinese-made Sinovac vaccine because of new findings that vaccine-induced antibodies fade over time, according to Reuters. Sinovac is the country's main vaccine, but worries about protection have been mounting in the wake of reports that hundreds of vaccinated health workers have died from COVID-19 since June.
A preprint study published a few days ago suggested that antibodies dipped below a key threshold about 6 months after the second Sinovac dose and that a third shot produced a strong booster effect.
More global headlines
· Elsewhere in Asia, officials in the Olympic host city of Tokyo today reported a sharp rise in cases, reaching a new daily high of 2,848 cases, according to the Japan Times. Japan's prime minister asked residents to stay home and avoid all unnecessary travel, and officials said the Delta (B1617.2) variant currently makes up 70% of sequenced samples.
· Australia's Victoria state said today that its COVID-19 measures will expire, as its flare-up winds down, but New South Wales state reported 172 more infections, up from 145 the day before, according to Reuters. The lockdown for the Sydney area, the state's hot spot, has been extended for 4 more weeks.
· Iran today recorded a new single-day high for cases, nearly 35,000, according to the Associated Press. As the hardest-hit country in the Middle East, Iran has only 3% of its population vaccinated, and hospitals in Tehran are reportedly overwhelmed by the country's Delta variant surge.
· COVID-related factory shutdowns in countries such as Vietnam, Indonesia, and Bangladesh are adding to supply chain woes in the United States, which could lead to back-to-school shortages of supplies, including clothing and shoes, according to the Washington Post. Chronic shipping delays are fueling inflation and could persist into 2022.
· The global COVID-19 total today rose to 194,697,770 cases, with at least 4,167,414 deaths, according to the New York Times
22 districts reporting an increasing trend in daily Covid cases, says Health Ministry
In past few weeks, there has been slowdown in rate of decline of average daily Covid cases: Centre
In the past few weeks, there has been a slowdown in the rate of decline of average daily Covid cases, which is a cause of concern, the Union health ministry said on Tuesday. It also said that there are 54 districts in 12 states and Union Territories, which reported over 10 per cent Covid positivity rate for the week ending July 26.
22 districts reporting an increasing trend in daily Covid cases, says Health Ministry
The Centre on Tuesday said that in past few weeks, there has been a slowdown in the rate of decline of average daily Covid cases which is cause of concern. At least,22 districts in sevenstates are reporting an increasing trend in daily Covid cases for last fourweeks, this is a cause of concern, the Health Ministry added.
Health Ministry says it will meet end-July domestic Covid-19 vaccine supply target
India will meet its target of supplying more than half a billion Covid-19 vaccine doses to states by the end of this month, the health ministry said on Tuesday, but added not all doses may be administered by then.
Tokyo looks to add hospital beds as Covid-19 cases rise (Reuters)
Supreme Court issues notice to Central & Delhi Govts on a petition seeking vaccination & rehabilitation of homeless & beggars amid COVID-19 pandemic across India.
Mizoram reported 9,531 active Covid cases, 137 deaths yesterday
COVID19 | Mizoram reported 9,531 active cases, 137 deaths, and 212 new recoveries, yesterday. Recovery rate at 71.09% and total cases at 33,452
Brazil health regulator cancels clinical study for Bharat Biotech vaccine
Brazilian health regulator Anvisa on Monday said it had canceled a clinical study for the Covaxin vaccine for Covid-19 developed by India's Bharat Biotech, amid allegations of irregularities in the government's efforts to buy millions of doses of the shot.
Bharat on Friday said it had terminated a memorandum of understanding with the local partner company acting as its intermediary in Brazil, with Anvisa saying on Monday that the trials could not go forward as a result and would be canceled.
'US committed to helping India on second Covid-19 wave'
The US remains committed to helping India recover from its devastating second wave of coronavirus and stands ready to support it until the virus is defeated, a top Biden administration official said on Monday.
Global growth to stay strong but virus the top risk, say economists
Global economic growth prospects are holding strong for this year and next, despite a significant majority of economists in Reuters polls warning new variants of the coronavirus pose the biggest risk to that outlook.
A global survey of nearly 500 economists taken this month also concluded recent rising inflation in key economies around the world would be transitory.
Russia approves trials of combined AstraZeneca/Sputnik V vaccine
Russia has given the green light for clinical trials combining a British shot from AstraZeneca Plc and Oxford University with Russia's Sputnik V vaccine to go ahead, according to Russia's state drug register. The health ministry's ethical committee had in May suspended the approval process for the clinical trials, and requested additional information.
The Covid crisis we don’t see
The official death-count due to Covid-19 in India stood at over 4,20,000 around mid-July. It is widely understood and accepted that the actual death toll is many times that figure. Yet, these numbers do not count the deaths of despair caused by a host of factors that are not directly due to Covid-19 but are indirectly a result of the pandemic— like suicides, caused by depression, anxiety, the devastation and deprivation of families whose lives have been upturned by the loss of a loved one or a financial crisis due to vanished incomes, or other reasons.
INVESTORS DIARY 2021
Company
Event
Venue
Date & Time
Companies under Cautionary
ART
PPC
Dairibord
Starafrica
Fidelity
Turnall
Medtech
Zimre
Nampak Zimbabwe
DISCLAIMER: This report has been prepared by Bulls ‘n Bears, a division of Faith Capital (Pvt) Ltd for general information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities. The information contained in this report has been compiled from sources believed to be reliable, but no representation or warranty is made or guarantee given as to its accuracy or completeness. All opinions expressed and recommendations made are subject to change without notice. Securities or financial instruments mentioned herein may not be suitable for all investors. Securities of emerging and mid-size growth companies typically involve a higher degree of risk and more volatility than the securities of more established companies. Neither Faith Capital nor any other member of Bulls ‘n Bears nor any other person, accepts any liability whatsoever for any loss howsoever arising from any use of this report or its contents or otherwise arising in connection therewith. Recipients of this report shall be solely responsible for making their own independent investigation into the business, financial condition and future prospects of any companies referred to in this report. Other Indices quoted herein are for guideline purposes only and sourced from third parties.
(c) 2021 Web: <http:// www.bullszimbabwe.com > www.bullszimbabwe.com Email: <mailto:info at bulls.co.zw> info at bulls.co.zw Tel: +263 4 2927658 Cell: +263 77 344 1674
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210728/204ac6b9/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 9458 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210728/204ac6b9/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.jpg
Type: image/jpeg
Size: 106747 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210728/204ac6b9/attachment-0001.jpg>
More information about the Bulls
mailing list